GlassScriptPhysician profile
Joshua Bornstein
NPI 1437500360
$1,791.87
in general payments reported to CMS, 2019-2025
20 companies · $982 in 2025
The $982 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $118 · 2021: $146 · 2022: $43.05 · 2024: $503 · 2025: $982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,484.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $353.05 | 2020-2025 | |
| Janssen Biotech, INC. | $232.27 | 2020-2025 | Tremfya |
| Genzyme Corporation | $169.20 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $148.34 | 2024-2025 | Dupixent |
| Pfizer INC. | $115.39 | 2020-2025 | |
| Sun Pharmaceutical Industries INC. | $104.00 | 2021-2025 | |
| Incyte Corporation | $103.54 | 2025 | Opzelura, Opzelura |
| Lilly USA, LLC | $96.64 | 2024-2025 | Ebglyss, Taltz |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.77 | 2024-2025 | Spevigo |
| Leo Pharma INC. | $85.60 | 2025 | Adbry, Spevigo |
| Ucb, INC. | $72.22 | 2024-2025 | Bimzelx |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $44.19 | 2021 | |
| Arcutis Biotherapeutics, INC. | $34.05 | 2025 | Zoryve |
| Genentech USA, INC. | $32.75 | 2024 | Xolair |
| Amgen INC. | $24.17 | 2025 | Otezla |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $20.91 | 2024 | Sotyktu |
| Lnhc, INC | $18.49 | 2025 | Zelsuvmi |
| Biofrontera INC. | $17.96 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.69 | 2020 | |
| Organon LLC | $12.64 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Bornstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.